H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12.4% of adults in Dallas have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Census population 1,304,379. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Dallas clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Dallas storefront.
Wharton's Jelly Allograft Products in Dallas, TX for clinics & physicians. Wharton's jelly allografts rich… Compliance support & pricing — contact Hawk Medical.
Dallas is a city of 1M+ (1,304,379 Census). CDC PLACES (2023, crude) estimates 12.4% of adults in Dallas have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Adult arthritis here is 18.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Keep 361 tissue, autologous PRP, and skin substitutes on different tickets. We onboard against that split — then ship.
National Wharton's Jelly Allograft Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 12.4% of adults in Dallas have diagnosed diabetes — 0.4 points above the U.S. 12% figure. Adult obesity in Dallas is 36.8% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 18.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JH / Novitas Solutions, sibling states AR, CO, LA, MS, NM, OK. Texas DSHS is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, JH articles mapped. 22.7% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 12.4% of adults — 0.4 points above the U.S. 12% figure. Obesity is 36.8%; arthritis is 18.9%. That is place-level BRFSS modeling, not a clinic census and not a Dallas trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Texas compliance risk.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
Use the contact form or book a 15-minute call with Joe Bradley. Bring specialty, monthly wound or joint volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy Dallas tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Dallas, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Dallas is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Dallas — 0.4 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Dallas. Useful for joint-program math; still needs a diagnosis and privileging.
No Dallas storefront. Joe Bradley is an active practice owner. whartons jelly allograft stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.